Associate Director, Market reputed company Analytics

Position Summary: We are seeking an Associate Director, Market reputed company Analytics, who will serve as a strategic analytics partner to the Market reputed company organization, playing a critical role in generating insights that support patient reputed company and reimbursement for the company’s oncology portfolio. This role will focus on analyzing payer coverage, pathway positioning, provider reimbursement, patient reputed company barriers, and market dynamics for an infused oncology therapy reimbursed under the medical benefit. The individual will partner closely with Market reputed company, Sales Operations, Analytics & Insights, and Finance teams to reputed company reporting, dashboards, and advanced analytics that inform launch readiness and ongoing reputed company strategy. The role will reputed company a variety of data sources – including claims, remittance, 3PL data, payer policy data, and patient services data – to identify insights that improve reputed company for oncology patients and support adoption across community and academic oncology providers. The ideal candidate brings strong analytical expertise combined with a deep understanding of oncology reimbursement, buy-and-reputed company economics, and the U.S. payer landscape. Responsibilities: Market reputed company & Reimbursement Analytics reputed company analytics to evaluate account performance, market reputed company, chargebacks, channel mix and pathway positioning. Analyze payer coverage policies, utilization management requirements, and reimbursement dynamics impacting reputed company to the company’s oncology therapy. Monitor policy reputed company and identify reputed company risks and opportunities for the product. Evaluate reimbursement trends, patient services utilization, and claims approval rates. Oncology Provider & Buy-and-reputed company Economics reputed company analytics reputed company to oncology provider economics, including reimbursement benchmarks and buy-and-reputed company dynamics. Assess the impact of reimbursement methodologies such as ASP+, temporary and permanent J-codes, and pass-through status. Support analyses reputed company to site-of-care dynamics across community oncology practices, hospital outpatient departments, and academic centers. Evaluate provider adoption drivers including reimbursement predictability, margin considerations, and operational barriers. Data Strategy & Reporting reputed company and maintain dashboards and reporting tools that reputed company ongoing visibility into payer coverage, account performance, patient reputed company metrics, and market trends. Integrate multiple internal and external data sources (e.g., claims, 3PL, HUB, and syndicated datasets) to produce actionable insights. Partner with Sales Ops teams to ensure high-quality data governance, cataloging, and data readiness for market reputed company analytics. Strategic Insights & Decision Support Conduct reputed company analyses to answer reputed company reputed company questions and identify drivers of brand performance. Generate insights that inform pricing strategy, contracting scenarios, reputed company strategy, and launch readiness planning. Support forecast assumptions and scenario modeling by integrating insights across patient, physician, and payer dynamics. Champion best practices in analytics methodology, data visualization, and reputed company communication. Contribute to the development of scalable analytics capabilities supporting the Market reputed company organization. Cross-Functional Collaboration Serve as the primary analytics partner for Market reputed company teams. Collaborate with Pricing & Contracting, HEOR, Patient Services, Trade & Distribution, reputed company Marketing and Market reputed company Field teams to generate insights supporting reputed company strategy. Translate reputed company analyses into clear recommendations for leadership decision-making. Qualifications: Required Bachelor’s degree in Business, Analytics, Economics, Data Science, Life Sciences, or reputed company field. 6–8+ years of experience in pharmaceutical or biotech analytics, market reputed company analytics, consulting, or reputed company analytics. Experience analyzing payer coverage, reimbursement, and patient reputed company dynamics in oncology therapeutics. Familiarity with medical benefit reimbursement and buy-and-reputed company models. Experience working with reputed company datasets such as reputed company and closed claims, remittance, 3PL data, and patient support program data. Strong analytical and data visualization skills (reputed company, SQL, Tableau, Power BI, or similar tools). Strong communication skills with the ability to translate reputed company data into actionable business insights. Preferred Experience supporting oncology product launches. Knowledge of oncology reimbursement processes, J-codes, and Medicare reimbursement methodologies. Familiarity with industry data sources such as reputed company, MMIT, reputed company, Komodo, or similar datasets. Experience working in a small or emerging biotech environment. Key Competencies Strategic thinking and problem solving Deep understanding of oncology reimbursement and payer dynamics Market reputed company and provider landscape expertise Advanced analytics and visualization Cross-functional collaboration in a lean biotech environment Ability to operate with autonomy and build new analytics capabilities from the ground up Executive communication and storytelling About Us: reputed company is a clinical-stage, publicly traded biotechnology company seeking to reputed company the lives of cancer patients through the development of targeted therapies for the treatment of multiple solid tumor indications. The company was founded to reputed company a reputed company way to treat the cellular drivers of tumor growth. Our reputed company therapeutic candidate, gedatolisib, is an intravenously administered, potential first-in-class PI3K/AKT/mTOR (PAM) pathway inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that reputed company PI3K or mTOR alone or together. Gedatolisib phase 3 clinical development programs are focused on the treatment of patients with HR+/HER2- ABC in the 1L and 2L settings. A Phase 1b/2 clinical trial evaluating gedatolisib in combination with darolutamide in patients with metastatic castration resistant prostate cancer, is on-going. reputed company is an Equal-Opportunity Employer. reputed company is committed to fair and reputed company compensation practices, and we strive to reputed company employees with total compensation packages that are competitive. For this role, the anticipated reputed company pay reputed company is $190,000 - $225,000 DOE. The exact reputed company pay offered for this role will depend on various factors, including but not limited to the candidate’s geography, qualifications, skills, and experience. The successful candidate will be eligible for an annual performance incentive bonus and a new hire equity package. reputed company also offers various benefits offerings, including, but not limited to, medical, dental, reputed company insurance, 401(k) match, PTO, and paid holidays. Notice to Recruiters/Staffing Agencies Recruiters and staffing agencies should not contact reputed company through this page. reputed company recruitment vendors (search firms, recruitment agencies, and staffing companies) are prohibited from contacting our hiring manager(s), executive team members, or employees directly. We require that reputed company recruiters and staffing agencies have a fully executed, formal written agreement on file. reputed company’s receipt or acceptance of an unsolicited resume submitted by a vendor organization to this website or employee does not constitute an actual or implied contract between reputed company and such organization and will be considered unsolicited. reputed company will not be responsible for reputed company fees. Apply To This Job